|
Author, Year Study/Trial Name | Comparison (IG vs. CG) | Population | Outcome Category | Outcome Definition | IG Proportion (95% CI) | CG Proportion (95% CI) |
|---|---|---|---|---|---|---|
| Garcia-Albeniz, 2020136 | Continued screening after age 70 vs. cessation of screening | Women ages 70 to 74 years with a life expectancy of at least 10 years | Incidence | 8-year cumulative risk of breast cancer diagnosis | 5.3 (NR) | 3.9 (NR) |
| Treatments received by women diagnosed with breast cancer* | Lumpectomy | 52.6 (51.8–53.4) | 36.5 (35.2–38.0) | |||
| Simple mastectomy | 11.3 (10.8–11.8) | 10.4 (9.5–11.3) | ||||
| Radical mastectomy | 13.9 (13.4–14.5) | 18.2 (17.0–19.4) | ||||
| Radiotherapy | 51.0 (50.3–51.8) | 39.9 (38.6–41.3) | ||||
| Chemotherapy | 15.2 (14.7–15.8) | 21.1 (20.0–22.1) | ||||
| Continued screening after age 75 vs. cessation of screening | Women ages 75 to 84 years with a life expectancy of at least 10 years | Incidence | 8-year cumulative risk of breast cancer diagnosis | 5.8 (NR) | 3.9 (NR) | |
| Treatments received by women diagnosed with breast cancer* | Lumpectomy | 48.8 (47.9–49.5) | 32.6 (31.5–33.8) | |||
| Simple mastectomy | 10.8 (10.3–11.2) | 10.1 (9.4–10.9) | ||||
| Radical mastectomy | 14.2 (13.7–14.6) | 17.0 (16.0–17.9) | ||||
| Radiotherapy | 41.2 (40.4–41.9) | 31.9 (30.7–33.1) | ||||
| Chemotherapy | 8.6 (8.3–9.1) | 11.5 (10.6–12.3) |
Percentages are standardized to the age group–specific distribution of age; comorbidity score; new diagnosis of Alzheimer disease, acute myocardial infarction, chronic heart failure, chronic kidney disease, chronic obstructive pulmonary disease, hip fracture, stroke, or cancer (lung, endometrial, or colorectal); and institutionalization in a long-term care center.
Abbreviations: CG=control group; CI=confidence interval; IG=intervention group; NR=not reported
From: Chapter 3, Results
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.